Key result
Transcutaneous/percutaneous vagus nerve stimulation has been actively researched for musculoskeletal pain since 2021, predominantly targeting chronic pain via auricular stimulation at 25-30 Hz.
Why the study?
Does transcutaneous or percutaneous vagus nerve stimulation improve musculoskeletal pain?
Does transcutaneous or percutaneous vagus nerve stimulation improve musculoskeletal pain?
Transcutaneous vagus nerve stimulation shows potential as a safe, non-pharmacological adjunctive treatment for musculoskeletal pain, though more high-quality clinical trials are needed to establish definitive evidence.
May support tVNS/pVNS for musculoskeletal pain in Korean medicine; leaves open optimal parameters and efficacy pending prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bae et al. (2024) conducted a review in Musculoskeletal pain (n=19). Transcutaneous/percutaneous vagus nerve stimulation was evaluated. Transcutaneous/percutaneous vagus nerve stimulation has been actively researched for musculoskeletal pain since 2021, predominantly targeting chronic pain via auricular stimulation at 25-30 Hz.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: